Longevity · Khavinson tetrapeptide (research)
Epithalon
- Drug class
- Khavinson tetrapeptide (research)
- Status
- Compounded (503A)
- Also known as
- Epitalon, AEDG peptide, Epithalamin analog
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What Epithalon is studied for
- Telomerase activation (in vitro and animal)
- Pineal-axis and melatonin rhythm support
- Longevity and age-related biomarker research
Mechanism of action
Activates telomerase in somatic cells, lengthening telomeres in cell culture. In vivo, it restores pineal-axis melatonin rhythm and modulates expression of genes linked to circadian regulation and DNA repair.
Frequently asked questions
What does the research show?
Most evidence is from Khavinson-lab studies in rodents and small Russian cohorts — showing extended median lifespan, restored melatonin rhythm, and improved age-related biomarkers. Independent replication is limited.
How is it dosed?
Typical research protocol: 5–10 mg subcutaneously daily for 10–20 days, 1–2 cycles per year. No validated clinical dose exists.
Is it safe?
Short-term human tolerability in published Russian studies appears good. Long-term safety, particularly any theoretical cancer-risk from telomerase activation, is not well characterized.
